Viewing data from:

CYCLACILLIN

ANDA

CYCLACILLIN | A062895 | TEVA PHARMACEUTICALS USA INC

2 strengths0 unique patents0 unique exclusivities

API Supply Chain0 active DMFs2 inactive

0 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

FERMENTA PRODUCTS INCInactiveCYCLACILLIN

DMF 135621998

TEVA PHARMACEUTICALS USA INCInactiveCYCLACILLIN

DMF 136801998

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 250MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Aug 4, 1988

No patent or exclusivity listings for this strength.

#002 — 500MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Aug 4, 1988